Table 3. Results of multivariate logistic analysis of data collected 14 days after initiating treatment for scabies in randomized controlled trial, Dakar, Senegal.
| Variable | ORa | 95% CI |
|---|---|---|
| Two applications of BBb | 2.04 | 0.89–4.66 |
| Oral IVb | 0.23 | 0.10–0.50 |
| Age > 15 years | 1.21 | 0.57–2.56 |
| Parasitology test positive | 1.04 | 0.52–2.08 |
| Compliant with treatment | 2.27 | 1.02–5.03 |
| No. of sites initially involved ≥ 6 | 0.83 | 0.21–3.19 |
| Superinfection before randomization | 1.28 | 0.61–2.69 |
| No. of family members with scabies > 5 | 0.70 | 0.43–1.16 |
BB, benzyl benzoate; CI, confidence interval; IV, ivermectin; OR, odds ratio. a Ratio of the odds of achieving a cure. b The reference group was composed of patients who received a single application of BB.